#healthcare

A Penn State study found that GPT-4 and similar large language models answer healthcare queries with nearly 76% accuracy, outperforming earlier AI models. The researchers tested 1,400 medical questions from a dermatology board exam, noting that while AI is improving, it still falls short of human expert performance and requires careful oversight before clinical use.

A GitHub repository by Joel Parker Henderson provides examples of AI-assisted medical diagnosis, demonstrating how AI models like Claude Opus 4.8 can be used to analyze symptoms and suggest potential diagnoses based on medical case scenarios.

AI is accelerating drug discovery and clinical trials, cutting costs and timelines to bring treatments to patients faster. The convergence of AI, biology, and computation is transforming healthcare with a hopeful outlook.

Swoop, a healthcare technology company, announced it has acquired NimbleRx, a prescription fulfillment and pharmacy connectivity platform. The acquisition adds Nimble's pharmacy network and delivery capabilities to Swoop's existing portfolio of healthcare services.

This article compiles an academic reading list of papers offering critical perspectives on using large language models (LLMs) to provide health advice, highlighting concerns about reliability, bias, medical competence, and potential harms to users seeking medical information.

An individual with locked-in syndrome describes being fully conscious but unable to move or speak, facing profound isolation. Despite the condition's severity, the person emphasizes the importance of mental resilience: "Despite everything, you are alive."

The article discusses the ethical dilemmas and unintended consequences of modern warfare technologies, particularly focusing on how autonomous weapons systems and cyber operations can cause harm beyond their intended targets, challenging the principle of "first, do no harm" in military contexts.

The article critiques the U.S. primary care system for being reactive, short-visit-based, and physician-centric, arguing it fails to address root causes of illness. It proposes "post-primary-care" as a model focused on proactive, evidence-based healing using nutrition, lifestyle, and root-cause investigation to truly manage chronic disease.

AI has the potential to transform medicine by improving diagnostics, personalizing treatment, and increasing efficiency, but faces challenges around data privacy, bias, and regulation. Successful integration will require collaboration across clinical, research, and policy domains.

AdventHealth is partnering with OpenAI to advance whole-person care by integrating artificial intelligence into its healthcare operations. The collaboration aims to improve patient outcomes, streamline clinical workflows, and enhance the experience for both patients and providers through AI-driven tools.

A study from Brown University finds that private equity acquisition of primary care practices leads to expanded patient access and workforce growth, including more physicians and advanced practice providers, potentially increasing overall primary care utilization.

The article discusses how a woman named Jen is trapped in a cycle of unhealthy relationships and self-destructive behaviors, feeling unable to leave her situation despite recognizing its toxicity. It explores the psychological and emotional barriers that keep her from making a change.

Saffron Health, a healthcare startup, is pivoting away from the healthcare sector, indicating a strategic shift in its business focus.

Despite high healthcare spending, American life expectancy has stagnated and fallen behind other wealthy nations. Researchers at Tufts University attribute this lag to systemic issues including chronic disease prevalence, fragmented healthcare access, and social determinants like poverty and inequality that undermine overall population health.

NYC Health and Hospitals confirmed that hackers stole medical data and fingerprints from a breach affecting at least 1.8 million people. The cyberattack exposed sensitive patient information, including biometric data, raising significant privacy and security concerns for the public health system.

The article covers the "Jelly Tide" gelatin gummy product, which has gone viral ahead of its anticipated 2026 release. It discusses the product's popularity and the buzz surrounding its launch on the official site.

Evidence-based medicine (EBM) is the use of current best scientific evidence to guide patient care, integrating clinical expertise and patient values. It prioritizes systematic reviews and randomized trials as high-quality evidence sources and is a foundational framework in modern healthcare.

Mayo Clinic is piloting AI that records and transcribes ER visits to generate clinical notes, reducing doctors' data entry burdens. The system raises privacy concerns over constant recording of sensitive patient conversations.

An internal health-ministry audit in Ontario found that AI notetakers used by doctors to summarize patient visits occasionally generated fabricated information, including made-up diagnoses or recommendations. The audit reviewed dozens of cases and identified inaccuracies in AI-generated notes, raising concerns about patient safety and the reliability of the technology in clinical settings.

Auditors in Ontario found that AI-powered note-taking tools used by doctors frequently contain basic factual errors, such as incorrect patient ages, medication dosages, and medical histories. The errors raise concerns about patient safety and the reliability of AI documentation in healthcare settings.

A UK study has found that one in seven people would prefer using AI chatbots over consulting a human doctor, highlighting a growing shift in how patients seek medical advice.

Medicare has introduced a new payment model designed to accommodate AI-driven healthcare technologies, but most of the tech industry remains unaware of the shift. The model aims to reimburse providers for AI-assisted diagnostics and treatments, signaling a major policy change that could accelerate adoption of AI in medicine.

ProPublica found that eviCore, a company used by major insurers like Cigna and UnitedHealthcare, frequently denies medically necessary care through rigid algorithms and strict denial targets, prioritizing insurer profits over patient health.

OpenEvidence, an AI tool designed for medical professionals, has been adopted by a majority of U.S. doctors who use it to quickly access clinical information and stay current with medical research, quietly becoming a standard resource in healthcare.

Greater Manchester has refused to sign up to the NHS's flagship Federated Data Platform, whose core technology is supplied by Palantir, citing ongoing concerns about data privacy, governance, and lack of local control. The region's health and care leaders argue the platform does not meet their requirements and have opted to develop their own alternative system instead.

A UK study found that about one in seven people would prefer consulting an AI chatbot over seeing a doctor. The research surveyed attitudes toward healthcare AI and revealed a notable minority favoring digital consultations for certain conditions, raising questions about trust and accessibility in modern medicine.

A study tested AI chatbots on clinical reasoning, finding that while they can match or outperform physicians in generating differential diagnoses, they still struggle with nuanced decision-making and common clinical errors, indicating they are not yet fully reliable as standalone diagnostic tools.

The article introduces the Unmet Needs Index, a data-driven ranking system that scores and compares diseases based on factors like disease burden, lack of effective treatments, and research neglect. It aims to highlight gaps in medical innovation and guide resource allocation toward the most underserved conditions.

President Trump announced that FDA Commissioner Dr. Marty Makary is leaving his post. Makary, who was appointed by Trump, has served as the head of the U.S. Food and Drug Administration.

NHS England has confirmed that staff from US data analytics company Palantir can access patient data as part of a contract to manage the NHS's Federated Data Platform. The arrangement has raised privacy concerns, though NHS officials say access is governed by strict data protection agreements and audits.